Back to User profile » Mr Vijay Nadipelli
Papers published by Mr Vijay Nadipelli:
An Updated Version of the Treatment Effectiveness Assessment (TEA) [Letter]
Ling W, Farabee D, Nadipelli VR, Perrochet B
Substance Abuse and Rehabilitation 2020, 11:21-22
Published Date: 17 February 2020
Patient-reported outcomes in schizophrenia patients treated with once-monthly extended-release risperidone in a long-term clinical study
Dhanda R, Varghese D, Nadipelli VR, Fava M, Joshi N, Solem CT, Graham JA, Learned SM, Heidbreder C
Patient Preference and Adherence 2019, 13:1037-1050
Published Date: 2 July 2019
Measuring recovery in opioid use disorder: clinical utility and psychometric properties of the Treatment Effectiveness Assessment
Ling W, Nadipelli VR, Solem CT, Farabee D, Ronquest NA, Perrochet B, Learned SM, Deshpande CG, Heidbreder C
Substance Abuse and Rehabilitation 2019, 10:13-21
Published Date: 5 June 2019
Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder
Ronquest NA, Willson TM, Montejano LB, Nadipelli VR, Wollschlaeger BA
Substance Abuse and Rehabilitation 2018, 9:59-78
Published Date: 21 September 2018
Factors associated with opioid overdose: a 10-year retrospective study of patients in a large integrated health care system
Boscarino JA, Kirchner HL, Pitcavage JM, Nadipelli VR, Ronquest NA, Fitzpatrick MH, Han JJ
Substance Abuse and Rehabilitation 2016, 7:131-141
Published Date: 16 September 2016